Breaks Categories: News

TuesdayJul 30, 2024 11:44 am

HempNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Long-Term Study Results Confirm Positive Results of Developing Treatment for AD

InMed Pharmaceuticals (NASDAQ: INM), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, is reporting on positive results from a long-term study of INM-901. The in vivo preclinical Alzheimer's disease (“AD”) involved seven months of dosing and confirms findings from an earlier short-term pilot study. The company reported that results from the study confirm improvements in cognitive function, memory and locomotor activity and show statistical significance in certain behavioral assessments.According to the announcement, InMed is moving forward with additional molecular analyses to better define the mechanisms of action and…

Continue Reading

ThursdayJul 25, 2024 1:04 pm

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Announces Significant Advancements Following Cargo Management Group Acquisition

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, today provided key updates following its acquisition of Cargo Management Group (“CMG”). The acquisition was completed in June and has been instrumental in developing GTVH’s four-pillar model and setting the stage for future growth within the organization. According to the company, the formation of LE Logistic LLC, a wholly owned subsidiary of GTVH, marked a major milestone in its journey towards future growth. This entity is expected to take full charge of the company’s logistics operations once the motor carrier (“MC”) authority from CMG is fully transferred and can be integrated.…

Continue Reading

TuesdayJul 16, 2024 1:31 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Makes Management Announcement, Plans for Strategic Growth

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is preparing for growth by executing a strategic growth plan. A key element of the plan includes expanding the company’s management team to enable efficient handling of a greater workload of projects and initiatives. With that in mind, the company has named Nelson Cabatuan as consulting chief strategic financial advisor; Cabatuan is currently serving as Lexaria CFO. In his new role, Cabatuan will leverage his skills in corporate finance and strategic industry relationships to focus on strategic opportunities. In addition, Lexaria is working on other research and development projects…

Continue Reading

TuesdayJul 09, 2024 3:20 pm

HempNewsBreaks – CannaCon Event to Propel Networking, Knowledge Exchange in Fast-Growing Sector

CannaCon, a premier conference company that produces state-of-the-art B2B events for cannabis businesses, marijuana entrepreneurs, investors, and community partners to showcase industry products, people, innovations, and technology, today announced plans to host the 5th CannaCon Midwest St.Paul on Aug. 16-17, 2024. The event, designed to drive growth of the cannabis industry in both the Midwest and nationally while creating lasting value for the sector through high-powered networking and knowledge exchange, is slated to take place at the iconic Saint Paul River Center in St. Paul, Minnesota. Like-minded entrepreneurs and industry professionals will convene for the event with a mission to…

Continue Reading

TuesdayJul 09, 2024 2:28 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes Dosing in Second GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that human pilot study #2, GLP-1-H24-2, has now completed all dosing. The final DehydraTECH study arm used a Rybelsus(R) composition processed with DehydraTECH that is compliant with the FDA’s Inactive Ingredient Database (“FDA IID”), delivered within an in-mouth dissolvable tablet. According to the announcement, this will be the first study designed to investigate whether DehydraTECH-enhanced semaglutide can absorb at any level systemically through the sublingual/buccal tissues of the mouth and throat with fewer side effects than from swallowed administration, and with some effective drug delivery into…

Continue Reading

MondayJul 08, 2024 3:50 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Secures New Patents for Antiviral Drug Delivery, Treating Epilepsy

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced three new patent awards. In the European Union, the company received a new patent in Lexaria’s patent family #6: Transdermal and/or Dermal Delivery of Lipophilic Active Agents. Following an earlier one granted in Canada, this is the company’s second patent in this family. In Canada, Lexaria has received a new patent in patent family #18: Compositions and Methods for Enhanced Delivery of Antiviral Agents. This is the company’s fourth granted patent in this family, which was previously granted in the U.S., Australia and Japan. Further, building…

Continue Reading

ThursdayJun 20, 2024 12:21 pm

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Announces Significant Progress on Destino Ranch Project

Golden Triangle Ventures (OTC: GTVH) (“GTV”) today provided an update on its premier project, Destino Ranch, which is being developed by the company’s entertainment division through its wholly owned subsidiary, Lavish Entertainment. Destino Ranch is a bold project led by Lavish, designed to provide a unique combination of world-class entertainment, opulent accommodations and immersive experiences. Lavish has made significant progress in developing Destino Ranch over the past six months, including a massive overhaul of the irrigation system and extensive cleanup efforts including the repair of perimeter fencing, reinstallation of gates, and opening of roadways around the project. Tree care has…

Continue Reading

TuesdayJun 18, 2024 2:17 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Engages CRO for DehydraTECH GLP-1 Human Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced it has hired a contract research organization (“CRO”) to oversee execution of the company’s 12-week chronic study GLP-1-H24-4. The study will evaluate various DehydraTECH-GLP-1 (glucagon-like peptide) formulations and other treatments with efficacy objectives of weight loss, blood sugar reduction and more. “This study will be the most comprehensive and impactful GLP-1 investigation that Lexaria has ever undertaken,” said John Docherty, president of Lexaria. “The greatly expanded scope compared to our previous studies will allow us to investigate DehydraTECH-GLP-1 safety and efficacy over an extended treatment duration…

Continue Reading

FridayJun 14, 2024 1:23 pm

HempNewsBreaks – Astrotech Corp. (NASDAQ: ASTC) Subsidiary Partners with Multistate Testing Lab to Market Proprietary AgLAB Solutions

Astrotech (NASDAQ: ASTC), an innovative science and technology company, and its subsidiary, AgLAB, have entered into a master lease agreement with SC Labs; the companies are working together to jointly market the AgLAB 1000-D2(TM) mass spectrometer and the AgLAB Maximum Value Process testing method to SC Labs customers. AgLAB has pioneered applications featuring the Astrotech Mass Spectrometer Technology that specifically target the hemp and cannabis markets while SC Labs, one of the largest multistate cannabis and hemp-testing labs in the United States, delivers industry-leading, science-based innovations in cannabis and hemp testing. The partnership between the two entities extends SC Labs’ analytical services directly…

Continue Reading

FridayJun 14, 2024 10:59 am

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Receives Full Financial Commitment to Move Forward with Launch of Freight Brokerage Division

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, has received the financial commitment required to launch an internal, full-service freight-brokerage business designed to significantly expand its logistics capabilities. GTVH made this announcement following the completed acquisition of Cargo Management Group from TK Zarro LLC; the acquisition includes a logistics operation, brokerage business, licenses and all associated assets. The announcement noted that the company received full financial support from TK Zarro to obtain state-of-the-art freight brokerage software, Transportation Management System (TMS), and load board subscriptions to streamline operations and improve service delivery. The announcement also stated that the transition will…

Continue Reading